Bull Case / Bear Case Framework
Force yourself to steelman both the optimistic and pessimistic future before forming a view.
- Difficulty
- Easy
- Time to result
- ~days to results
- Steps
- 5
- Confidence
- 80%
A simple but disciplined method for evaluating a company's forward prospects by explicitly stating the single core question that would validate an optimistic thesis, then separately building out the strongest evidence-based case for both a bullish and a bearish outcome. Rather than defaulting to whichever narrative is more exciting, the framework requires citing concrete historical precedent for the upside and naming specific, falsifiable risks for the downside, so that uncertainty is acknowledged honestly rather than resolved with false precision.
Origin
A standard closing segment on the Acquired podcast used to summarize the investment thesis for nearly every company covered.
Core principles
- 01State the single question whose answer determines the whole thesis
- 02Support the bull case with real historical precedent, not just optimism
- 03The bear case must name specific, checkable risks, not vague doubt
- 04Acknowledge genuine uncertainty rather than forcing a false conclusion
How to run it
- 1
State the core question
Identify the single question whose answer would determine whether the bullish thesis holds.
- 2
Build the bull case
List the concrete tailwinds and barriers to entry that support sustained upside if the core question resolves favorably.
- 3
Quantify with precedent
Reference comparable historical outcomes to size how large the opportunity could realistically become.
Pro tip Use precedent as an illustration of scale, not a guarantee of the same outcome.
- 4
Build the bear case
List the specific, checkable risks or unknowns that could invalidate the bullish thesis.
Watch out Don't let confirmation bias cause you to skip or soften the bear case.
- 5
Weigh and conclude honestly
State which scenario currently seems more likely and what new evidence would change that view, without forcing false certainty.
In the wild
The hosts frame Novo Nordisk and Eli Lilly's GLP-1 opportunity around one question: are GLP-1s the next multi-decade super cycle like insulin was? The bull case cites huge barriers to entry and room for multiple winners; the bear case cites unresolved long-term safety questions like lean muscle mass loss.
→ A balanced view that acknowledges massive upside potential while flagging real unresolved risk.
Common mistakes
Only presenting the bull case
Confirmation bias can lead analysts to build an exciting upside case while glossing over real risks.
Ignoring emerging disconfirming data
Early safety or efficacy signals, even if preliminary, should be weighed seriously rather than dismissed because they complicate the thesis.
Treating precedent as guaranteed
Citing a past blockbuster's results to size an opportunity is illustrative, not a promise that the new situation will play out identically.
Is it for you?
Best for
Investors and operators forming a quick, balanced view on a company's forward prospects
Not ideal for
Situations requiring precise quantitative modeling rather than a qualitative thesis check
From the transcript
“are gp1s the next Super Cycle if yes that is the bull case”
“the bare case is for any variety of reasons be it uh health risk or lack of efficacy or you know whatever long term this…”
From the episode
Novo Nordisk (Ozempic)